Business Description
Oncodesign Precision Medicine SA
ISIN : FR001400CM63
Compare
Compare
Traded in other countries / regions
ALOPM.FranceZR8.Germany IPO Date
2022-10-05Description
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.17 | |||||
| Equity-to-Asset | 0.22 | |||||
| Debt-to-Equity | 2.39 | |||||
| Debt-to-EBITDA | -0.99 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -1.16 | |||||
| Beneish M-Score | 1.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -53.7 | |||||
| 3-Year EBITDA Growth Rate | 13.9 | |||||
| 3-Year EPS without NRI Growth Rate | 10.8 | |||||
| 3-Year Book Growth Rate | -39.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 60.33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.56 | |||||
| 9-Day RSI | 13.77 | |||||
| 14-Day RSI | 21.19 | |||||
| 6-1 Month Momentum % | 1.96 | |||||
| 12-1 Month Momentum % | -43.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | |||||
| Quick Ratio | 3.5 | |||||
| Cash Ratio | 2.51 | |||||
| Days Sales Outstanding | 688.4 | |||||
| Days Payable | 174.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -34.4 | |||||
| Shareholder Yield % | -21.74 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -1442.16 | |||||
| Operating Margin % | -2138.17 | |||||
| Net Margin % | -1814.05 | |||||
| ROE % | -99.7 | |||||
| ROA % | -46.5 | |||||
| ROIC % | -353.72 | |||||
| ROC (Joel Greenblatt) % | -1086.49 | |||||
| ROCE % | -72.55 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 6.89 | |||||
| PS Ratio | 29.23 | |||||
| PB Ratio | 3.42 | |||||
| Price-to-Tangible-Book | 5.07 | |||||
| EV-to-EBIT | -1.37 | |||||
| EV-to-EBITDA | -1.39 | |||||
| EV-to-Revenue | 28.8 | |||||
| Price-to-Net-Current-Asset-Value | 8.44 | |||||
| Earnings Yield (Greenblatt) % | -72.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oncodesign Precision Medicine SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.427 | ||
| EPS (TTM) (€) | -0.447 | ||
| Beta | 0 | ||
| Volatility % | 48.35 | ||
| 14-Day RSI | 21.19 | ||
| 14-Day ATR (€) | 0.056867 | ||
| 20-Day SMA (€) | 0.9919 | ||
| 12-1 Month Momentum % | -43.63 | ||
| 52-Week Range (€) | 0.73 - 2.06 | ||
| Shares Outstanding (Mil) | 18.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oncodesign Precision Medicine SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oncodesign Precision Medicine SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oncodesign Precision Medicine SA Frequently Asked Questions
What is Oncodesign Precision Medicine SA(XPAR:ALOPM)'s stock price today?
The current price of XPAR:ALOPM is €0.76. The 52 week high of XPAR:ALOPM is €2.06 and 52 week low is €0.73.
When is next earnings date of Oncodesign Precision Medicine SA(XPAR:ALOPM)?
The next earnings date of Oncodesign Precision Medicine SA(XPAR:ALOPM) is .
Does Oncodesign Precision Medicine SA(XPAR:ALOPM) pay dividends? If so, how much?
Oncodesign Precision Medicine SA(XPAR:ALOPM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers